We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2082:TADAWULACWA Power Company Analysis

Data as of 2026-08-11 - not real-time

SAR 184.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ACWA Power Company is priced at SAR 184.00, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 5.2%. Momentum indicators put RSI at 42.5 (neutral) with MACD reading bearish. Price has been bracketed by support at SAR 178.60 and resistance at SAR 202.20.
Valuation screens as overvalued: a P/E of 87.6 sits above the sector average of 19.9. Sell-side targets cluster 21.2% below the current quote. Revenue is growing at 15.1% on a 20.6% profit margin. The 0.25% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 30.1%, a beta of 0.20 and a maximum drawdown of 37.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to sell, carrying 5/10 conviction.

Top Market Events

Yahoo Finance2monACWA Power Co SAU:2082 Q1 2026 Earnings Call Highlights: Navigating Financial Challenges and .Barron's19dAcwa Power Co.ACWA Power Co. develops, owns, and operates independent water and power projects. It operates...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 186.44
  • MACD momentum is negative
  • 30-day price change of -5.2%

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 87.6 versus sector average of 19.9
  • Dividend yield of 0.25% looks stretched against payout coverage
  • Trading below the 200-day average of 186.44

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 87.6 versus sector average of 19.9
  • Dividend yield of 0.25% looks stretched against payout coverage
  • Analyst targets imply -21.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin20.64%
P/E Ratio87.6
ROE5.99%
ROA1.76%
Debt/Equity97.85
P/B Ratio9.4
Op. Cash FlowSAR4.2B
Free Cash FlowSAR-3046771456
Industry P/E19.9

Technical Analysis

TrendNeutral
RSI42.5
SupportSAR 178.60
ResistanceSAR 202.20
MA 20SAR 189.72
MA 50SAR 192.87
MA 200SAR 186.44
MACDBearish
VolumeIncreasing
Fear & Greed Index94.16

Valuation

Fair ValueSAR 60.28
Target PriceSAR 145.00
Upside/Downside-21.20%
GradeOvervalued
TypeGrowth
Dividend Yield0.25%

Risk Assessment

Beta0.20
Volatility30.13%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.